Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Gains 6%; BSE HEALTHCARE Index Down 0.3%
Thu, 20 Jun 13:17

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 6% and is presently trading at Rs 444.9.

Meanwhile, the BSE HEALTHCARE index is at 36,728.0 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 3.7%) and Biocon (up 2.4%).

SUVEN PHARMACEUTICALS (down 3.0%) and Sanofi India (down 2.7%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 352.3 to Rs 444.9, registering a gain of Rs 92.6 (up 26.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,118.0 to 36,728.0, registering a gain of 46.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 94.9%), Glenmark Pharma (up 94.7%) and Lupin (up 88.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 77,459.9 (up 0.2%).

The top gainers among the BSE Sensex today are JSW Steel (up 2.2%) and Reliance Ind. (up 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 23,552.5 (up 0.2%). Hindalco and JSW Steel are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,168.3 to 77,459.9, registering a gain of 14,291.6 points (up 22.6%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit fell 6912.0% YoY to Rs -2,555 million for the quarter ended March 2024, compared to a profit of Rs 38 million a year ago. Net sales declined 21.3% to Rs 2,994 million during the period as against Rs 3,806 million in January-March 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -3.8.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 6%; BSE HEALTHCARE Index Down 0.3%". Click here!